Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Cole

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2021
How cancer programs identify and address the financial burdens of rural cancer patientsVictoria Petermann, Whitney E Zahnd, Robin C Vanderpool, et al.
Cancer Causes & Control : CCC|February 25, 2023
Prioritizing rural populations in state comprehensive cancer control plans: a qualitative assessmentRachel Hirschey, Catherine Rohweder, Whitney E Zahnd, et al.
Journal of Cancer Survivorship : Research and Practice|January 26, 2022
Financial navigation: Staff perspectives on patients' financial burden of cancer careKatherine A Yeager, Whitney E Zahnd, Jan M Eberth, et al.
Journal of Cancer Survivorship : Research and Practice|February 23, 2022
Correction to: Financial navigation: staff perspectives on patients' financial burden of cancer careKatherine A Yeager, Whitney E Zahnd, Jan M Eberth, et al.
BMC Cancer|January 9, 2025
Cancer-related health behaviors during the COVID 19 pandemic in geographically diverse samples across the USBreanna B Greteman, Allison Cole, Mary E Charlton, et al.
Journal for Immunotherapy of Cancer|January 13, 2023
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammationViktoria Marquardt, Johanna Theruvath, David Pauck, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 16, 2021
How cancer programs identify and address the financial burdens of rural cancer patientsVictoria Petermann, Whitney E Zahnd, Robin C Vanderpool, et al.
Cancer Causes & Control : CCC|February 25, 2023
Prioritizing rural populations in state comprehensive cancer control plans: a qualitative assessmentRachel Hirschey, Catherine Rohweder, Whitney E Zahnd, et al.
Journal of Cancer Survivorship : Research and Practice|January 26, 2022
Financial navigation: Staff perspectives on patients' financial burden of cancer careKatherine A Yeager, Whitney E Zahnd, Jan M Eberth, et al.
Journal of Cancer Survivorship : Research and Practice|February 23, 2022
Correction to: Financial navigation: staff perspectives on patients' financial burden of cancer careKatherine A Yeager, Whitney E Zahnd, Jan M Eberth, et al.
BMC Cancer|January 9, 2025
Cancer-related health behaviors during the COVID 19 pandemic in geographically diverse samples across the USBreanna B Greteman, Allison Cole, Mary E Charlton, et al.
Journal for Immunotherapy of Cancer|January 13, 2023
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammationViktoria Marquardt, Johanna Theruvath, David Pauck, et al.
Pageof 5